Abstract:The role of TL1A in the intestinal mucosa barrier in inflammatory bowel disease (IBD) is still unclear. This study was aimed to investigate the expression levels of tight junction protein (TJ), myosin light chain kinase (MLCK), MyD88 and tumor necrosis factor (TNF) receptor-associated factor-6 (TRAF6) and how TL1A influences the intestinal barrier in IBD. The mouse models of IBD were built using FMS-TL1A-GFP-transgenic mice and wild-type mice. The morphological and histopathological changes, bacterial translocation, permeability of colonic mucosa, and LPS level were assessed. Caco-2 cells were used to further investigate the association between TL1A and TNF-α and LPS. The protein level and mRNA changes of TJ proteins including ZO-1, occluding, JAMA, claudin-1, claudin-2, and claudin-3 were investigated using Western blot and real-time PCR. Protein changes of MLCK, MyD88 and TNF receptor-associated factor-6 (TRAF6), and TNF-α mRNA in the mouse colon were further assessed. The IBD models were successfully built. Cooper HS score and histopathological score of the colon were higher in DSS/WT group than in control/WT group (P < 0.05), higher in DSS/Tg group than in control/Tg group (P < 0.05), and higher in DSS/Tg group than in DSS/WT group. PAS, colonic permeability of the colon, and FITC-D examination showed the similar results and trends. Compared with control/WT group, the levels of TL1A and claudin-2 were higher and the levels of ZO-1, occludin, JAMA, claudin-1, and claudin-3 were lower in DSS/WT group (P < 0.05). Compared with control/Tg group, the levels of TL1A and claudin-2 were higher and the levels of ZO-1, occludin, JAMA, claudin-1, and claudin-3 were lower in DSS/Tg group. Compared with Caco-2 + TNF-α group, the expression level of occludin and claudin-1 in Caco-2 + LV-TNFSF15 + TNF-α group was significantly lower (P < 0.05); p-MLC level was significantly higher. Compared with Caco-2 + LPS group, the expression level of occludin and claudin-1 significantly decreased in Caco-2 + LV-TNFSF15 + LPS group; MyD88 and TRAF6 expression level significantly increased. The results suggested that TL1A could impair intestinal epithelial barrier in the mouse model of IBD and might regulate TJ expression via MLCK/p-MLC pathway and LPS-mediated MyD88/TRAF6 pathway.

L-theanine Attenuates Porcine Intestinal Tight Junction Damage Induced by LPS Via P38 MAPK/NLRP3 Signaling in IPEC-J2 Cells

L-theanine attenuates H 2 O 2 -induced inflammation and apoptosis in IPEC-J2 cells via inhibiting p38 MAPK signaling pathway

L-theanine Attenuates H2O2-induced Inflammation and Apoptosis in IPEC-J2 Cells Via Inhibiting P38 MAPK Signaling Pathway

Effects and Mechanism of Constitutive TL1A Expression on Intestinal Mucosal Barrier in DSS-Induced Colitis

Ginsenoside Rg1 Mitigates Porcine Intestinal Tight Junction Disruptions Induced by LPS through the p38 MAPK/NLRP3 Inflammasome Pathway

L-theanine improves intestinal barrier functions by increasing tight junction protein expression and attenuating inflammatory reaction in weaned piglets

Protective Effects of L-Theanine on IPEC-J2 Cells Growth Inhibition Induced by Dextran Sulfate Sodium via p53 Signaling Pathway

Protective effect of L-theanine on intestinal barrier in heat-stressed organisms

Topical Delivery of L -Theanine Ameliorates TPA-induced Acute Skin Inflammation Via Downregulating Endothelial PECAM-1 and Neutrophil Infiltration and Activation

l-Theanine prevents ETEC-induced liver damage by reducing intrinsic apoptotic response and inhibiting ERK1/2 and JNK1/2 signaling pathways.

Immune-modulatory Effects and Mechanism of Action of L-Theanine on ETEC-induced Immune-Stressed Mice Via Nucleotide-Binding Oligomerization Domain-Like Receptor Signaling Pathway

Dietary l-tryptophan alleviated LPS-induced intestinal barrier injury by regulating tight junctions in a Caco-2 cell monolayer model

Lactoferrin Attenuates Lipopolysaccharide-Stimulated Inflammatory Responses and Barrier Impairment Through the Modulation of NF-κB/MAPK/Nrf2 Pathways in IPEC-J2 Cells.

Trans-anethole ameliorates LPS-induced inflammation via suppression of TLR4/NF-κB pathway in IEC-6 cells

Supplementation with L-theanine Promotes Intestinal Antioxidant Ability Via Nrf2 Signaling Pathway in Weaning Piglets and H2O2-induced IPEC-J2 Cells

Lactobacillus fermentum ZYL0401 Attenuates Lipopolysaccharide-Induced Hepatic TNF-α Expression and Liver Injury via an IL-10- and PGE2-EP4-Dependent Mechanism.

L-Theanine Affects Intestinal Mucosal Immunity by Regulating Short-Chain Fatty Acid Metabolism under Dietary Fiber Feeding.

Epigallocatechin-3-gallate Ameliorates LPS-induced Inflammation by Inhibiting the Phosphorylation of Akt and ERK Signaling Molecules in Rat H9c2 Cells

Clostridium Tyrobutyricum Protect Intestinal Barrier Function from LPS-Induced Apoptosis Via P38/JNK Signaling Pathway in IPEC-J2 Cells

Betaine attenuates LPS-induced downregulation of Occludin and Claudin-1 and restores intestinal barrier function

Protective effects of Lactobacillus plantarum on epithelial barrier disruption caused by enterotoxigenic Escherichia coli in intestinal porcine epithelial cells